A nomogram useful for screening atherosclerosis in CKD patients without dialysis: Study Dr. Shravani Dali20 July 2021 8:45 AM ISTA nomogram is beneficial and might be instrumental for detecting subclinical atherosclerosis in patients with CKD without dialysis, suggests a study...
FDA panel votes against use of Roxadustat for anaemia in CKD patients Dr. Shravani Dali17 July 2021 6:55 PM ISTFibroGen, Inc., a leading biopharmaceutical company headquartered in San Francisco recently announced that the Cardiovascular and Renal Drugs...
Sotagliflozin use linked to reduced risk of heart attack, heart failure and stroke in diabetics: Study Medha Baranwal15 July 2021 9:00 AM ISTSotagliflozin is not FDA approved and if it is brought to the market, it would signify a major advance in the care of patients with diabetes,...
Chronic Kidney Disease More Common In Cancer Patients: Study MD Bureau13 July 2021 9:00 AM ISTThe incidence of CKD is higher among cancer patients than in the general population. Timisoara, Romania: Cancer patients are at a greater risk for...
Bayer Finerenone gets USFDA approval to treat CKD associated with type 2 diabetes Ruchika Sharma11 July 2021 10:00 AM ISTBerlin: Bayer has announced that the U.S. Food and Drug Administration (FDA) has approved finerenone, the first non-steroidal, selective...
EMPEROR-Preserved confirms success of Empagliflozin in HFpEF Hina Zahid8 July 2021 9:45 AM ISTEmpagliflozin therapy with specific benefits in patients with heart failure and preserved ejection fraction (HFpEF) may finally be on its way as the...
Finerenone improves kidney outcomes in patients of CKD with diabetes: Study Medha Baranwal2 July 2021 9:00 AM ISTDelhi: Finerenone exerts renoprotective benefits in patients with chronic kidney disease (CKD) and type 2 diabetes (T2D) irrespective of absence or...
Inflammatory skin diseases linked to chronic kidney disease: Study Dr. Nandita Mohan30 Jun 2021 9:15 AM ISTResearchers from a recent study have found out that inflammatory skin diseases like atopic eczema, psoriasis and hidradenitis suppurativa are weakly...
Dapagliflozin reduces risk of new type 2 diabetes in CKD patients: Study Medha Baranwal30 Jun 2021 9:00 AM ISTDelhi: Treatment with dapagliflozin in chronic kidney disease (CKD) patients significantly reduced the risk of new-onset type 2 diabetes (T2D), show...
Regular efpeglenatide use significantly reduces cardiorenal events in diabetics: AMPLITUDE O Trial Medha Baranwal29 Jun 2021 10:15 AM ISTUSA: Weekly injection of efpeglenatide has the potential to improve outcomes for high-risk diabetes patients with heart or kidney disease, shows...
Mankind Pharma launches Dapagliflozin brand Justoza for diabetes, heart failure, CKD Ruchika Sharma23 Jun 2021 1:30 PM ISTNew Delhi: Mankind Pharma has launched Justoza, a Dapagliflozin brand marketed by Mankind to treat Diabetes, Heart Failure and Chronic...
KDIGO updates Guideline on BP management in patients with chronic kidney disease Medha Baranwal22 Jun 2021 5:30 PM ISTDelhi: The Kidney Disease: Improving Global Outcomes (KDIGO) organization has released the latest clinical practice guideline for the management of...
